Pantothenate Kinase-Associated Neurodegeneration
5 clinical trials · Condition
◉ Watch Pantothenate Kinase-Associated Neurodegeneration
| Record | Firm | Date |
|---|---|---|
| CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN) (NCT04182763) | Oregon Health and Science University | 2019-12-04 |
| Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants (NCT03041116) | Travere Therapeutics, Inc. | 2017-07-17 |
| Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration (NCT02174848) | ApoPharma | 2014-06-01 |
| Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN) (NCT01741532) | ApoPharma | 2012-12-13 |
| Compassionate Use of Deferiprone in Patients With PKAN (NCT02635841) | Chiesi Canada Corp |
Track Pantothenate Kinase-Associated Neurodegeneration automatically
Every clearance here is in the API, with alerts when new ones post.